{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.0","value":"74.5"},{"groupId":"OG001","spread":"1.0","value":"74.2"}]}],"title":"Prior to surgery"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.3","value":"69.3"},{"groupId":"OG001","spread":"1.3","value":"68.4"}]}],"title":"6 weeks post-surgery"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.3","value":"68.7"},{"groupId":"OG001","spread":"1.3","value":"68.8"}]}],"title":"15 weeks post-surgery"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.3","value":"72.6"},{"groupId":"OG001","spread":"1.3","value":"73.5"}]}],"title":"6 months post-surgery"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.4","value":"74.0"},{"groupId":"OG001","spread":"1.3","value":"75.6"}]}],"title":"12 months post-surgery"}],"denoms":[{"counts":[{"groupId":"OG000","value":"215"},{"groupId":"OG001","value":"206"}],"units":"Participants"}],"description":"Patient reported quality of life was measured with the Treatment Outcome Index (TOI) of the Functional Assessment of Cancer Therapy for ovarian cancer (FACT-O TOI). The FACT-O TOI is a scale for assessing general QOL of ovarian cancer patients. It consists of three subscales: Physical Well Being (7 items), Functional Well Being (7 items), and Ovarian Cancer subscale (11 items). Each item in the FACT-O TOI was scored using a 5-point scale (0=not at all; 1=a little bit; 2=somewhat; 3=quite a bit; 4=very much). The FACT-O TOI score ranges 0-100 with a large score suggests better QOL.","dispersionType":"Standard Error","groups":[{"description":"All patients enrolled in the study who did not receive cytoreductive surgery and included in the surgery analysis","id":"OG000","title":"No Cytoreductive Surgery"},{"description":"All patients enrolled in the study who received secondary cytoreductive surgery and were included in the surgery analysis","id":"OG001","title":"Cytoreductive Surgery"}],"paramType":"LEAST_SQUARES_MEAN","populationDescription":"Provided baseline and at least one follow-up assessment (data were combined and analyzed according to randomized surgical assignment, regardless of chemotherapy regimen, as pre-specified in the study protocol).","reportingStatus":"POSTED","timeFrame":"1. Prior to surgery, 2. 6 weeks post-surgery, 3. 15 weeks post-surgery, 4. 6 months post-surgery, 5. 12 months post-surgery.","title":"Patient Reported Quality of Life (Surgery Analysis)","type":"SECONDARY","unitOfMeasure":"score on a scale"}